SBC Medical Group Holdings Incorporated: stock overview

SBCNASDAQHealthcare · Services-Offices & Clinics of Doctors of Medicine

Price

$7.35

November 13, 2026Market cap $754M

DCF calculator

What Ploutos Investor adds for SBC Medical Group

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 3 fiscal years, from 2023
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has risen 130% since Aug 13, 2026, when the 10-Q these figures come from was filed ($3.19 then, $7.35 on Nov 13, 2026). The figures date from before that move.10-Q

In short

SBC Medical Group had revenue of $190M over the last 12 months and net income of $52M, a net margin of 27.3%. Revenue fell by 5.3% a year on average over the last 2 years. At $7.35 the shares trade at a P/E of 14.5, against a median of 11.6 over the last 3 fiscal years. It holds more cash than debt, by $156M. It pays no dividend.

From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.

Its SEC filings
Market cap
$754M
103M shares
P/E
14.5
Today14.5
Median11.6
Revenue, 12 months
$190M
-5.3% a year over 2 years
Net margin
27.3%
2025: 29.4%, above 98% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

2023–2025 fiscal years

-5.3% a year over 2 years

  • 202510-K
    Revenue$174M
  • 202410-K
    Revenue$205M
  • 202310-K
    Revenue$194M

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $576M
$754M
Enterprise value 
$598M
P/E 3-year median: 11.6
14.5
EV / EBIT 
7.9
EV / Revenue 
3.1
P/B 3-year median: 3.0
2.6
FCF yield 3-year median: 4.2%
13.3%
Earnings yield 3-year median: 8.6%
6.9%

Profitability

Gross margin 
72.2%
Operating margin 
39.9%
Net margin 3-year median: 22.7%
27.3%
ROIC 
16.3%
ROIC, 5-year average 
27.3%
ROE 
19.9%

Growth

Revenue, yearly change 
-15.5%
EPS, yearly change 
+4.2%
FCF, yearly change 
+29.1%
Revenue, average a year 
-5.3%
EPS, average a year 
+9.1%

The yearly change compares FY2025 with FY2024.

Balance sheet

Cash 
$199M
Total debt 
$53M
Of which operating leases 
$10M
Net cash 
$156M
Net debt / EBITDA 
-2.0x
Interest cover 
181.9x
Current ratio 
3.67

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
0.66%
Total returned 
0.66%
Shares, yearly change 
-1.0%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 80).

Gross margin

73.3%

Above 86% of the 25 companies in its industry, and 89% of all.

Operating margin

38.9%

Above 98% of the 62 companies in its industry, and 96% of all.

Net margin

29.4%

Above 98% of the 68 companies in its industry, and 91% of all.

ROE

20.5%

Above 91% of the 58 companies in its industry, and 84% of all.

ROA

13.4%

Above 96% of the 69 companies in its industry, and 93% of all.

Revenue growth

-15.5%

Above 5% of the 68 companies in its industry, and 6% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
SBC Medical Group Holdings Inc
CIK
1930313
Exchange
NASDAQ
Industry (SIC)
8011 · Services-Offices & Clinics of Doctors of Medicine
Fiscal year ends
December 31
Latest annual report
December 31, 2025
Reporting currency
USD
Shares
103M

Other companies: Healthcare

The largest companies of the same sector, each with its own page.

The Healthcare sectorAll companies

The full analysis

What do SBC Medical Group's filings show?

These are SBC Medical Group's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about SBC

Didn't find what you were looking for?

Ask us
What is SBC's market cap?

SBC Medical Group Holdings Incorporated's market cap is $754M, at a price of $7.35 on November 13, 2026 and 103M shares.

What is SBC's P/E?

SBC's P/E is 14.5, on earnings per share of $0.50 over the last 12 months. The median over the last 3 fiscal years was 11.6.

How much revenue does SBC have?

SBC Medical Group had revenue of $190M over the last 12 months. Over the last 2 years it changed by -5.3% a year on average.

Does SBC pay a dividend?

No. SBC Medical Group paid no regular dividend over the last 12 months.

Where do the figures come from?

From SBC Medical Group Holdings Incorporated's SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.